Abstract:Background: Moyamoya disease (MMD) is a rare, progressive steno-occlusive cerebrovascular disorder of the internal carotid artery, leading to stroke. Affected arteries exhibited thickened intima with depleted elastic lamina and media, indicating a dysfunction of the vascular smooth muscle cells (VSMCs) and endothelial cells (ECs). However, the pathogenesis of the disease is still unclear. We aim to address this gap in knowledge by using patient derived induced pluripotent stem cells (iPSCs), to generate VSMCs and ECs. Methods: Peripheral blood mononuclear cells (PBMCs) from controls and MMD patients (n=3 per group) were used for generating iPSCs. Functional properties of differentiated ECs and VSMCs in normoxia/hypoxia model (1%O 2 ) were assessed for cell proliferation by BrDU incorporation, migration by scratch assays and apoptosis by exposure to hydrogen peroxide (H2O2). In vitro angiogenic tube formation was assessed with ECs alone, as well as ECs and VSMCs as a co-culture. Hypoxia inducible factor 1α (HIF1α) and Intercellular adhesion molecule-1 (ICAM-1) activation was determined using qPCR and western blot in VSMCs. Results: Functional proliferative assays showed that MMD ECs proliferated faster than control ECs. Migration assays showed that MMD ECs migrate slower in response to VEGF after hypoxia. MMD ECs were found to be more sensitive to insults such as H2O2 treatment and exhibited more apoptosis. In contrast, MMD VSMCs proliferate and migrate similar to controls, but exhibited elevated levels of HIF1α, ICAM-1 mRNA and protein expression. MMD and control ECs showed similar levels of tube formation in single cultures, however, when co-culturing with VSMCs, MMD VSMCs failed to support EC tubes beyond 24 h, resulting in tube destabilization. Conclusions: Our preliminary results indicate that both MMD VSMCs and ECs are dysfunctional and may be related to the elevated expression of HIF1α and ICAM-1, possibly contributing to MMD pathology. Current ongoing studies include investigating the interactions between MMD VSMCs and ECs using co-cultures, as well as transcriptome analysis of these differentiated cells, which will provide important insights into the cellular and molecular mechanisms underlying MMD.

Desmoglein-2 Affects Vascular Function in Moyamoya Disease by Interacting with MMP-9 and Influencing PI3K Signaling

Significance of Serum Angiopoietin-2 in Patients with Hemorrhage in Adult-Onset Moyamoya Disease

Differential Expression of Vascular Endothelial Growth Factor-A165 Isoforms Between Intracranial Atherosclerosis and Moyamoya Disease.

Proteomics and digital subtraction angiography approaches reveal CDH18 as a potential target for therapy of moyamoya disease

Organoid Modeling and Single-Cell Profiling Uncover the Migration Mechanism of Smooth Muscle Cells in Moyamoya Disease

The prognostic values of plasma desmosines, crosslinking molecules of elastic fibers, in the disease progression of Moyamoya disease

Molecular Biomarkers Affecting Moyamoya Disease

Abstract P749: Functional and Molecular Characterization of Endothelial and Vascular Smooth Muscle Cells Derived From Moyamoya Disease-Induced Pluripotent Stem Cells

GM-CSF Promotes the Development of Dysfunctional Vascular Networks in Moyamoya Disease

Increased Levels of Circulating SDF‐1α and CD34+ CXCR4+ Cells in Patients with Moyamoya Disease

Pathological Circulating Factors in Moyamoya Disease

Bradykinin‐bradykinin receptor (B1R) signalling is involved in the blood–brain barrier disruption in moyamoya disease

Insights into the regulatory role of epigenetics in moyamoya disease: Current advances and future prospectives

Cyclooxygenase-2 and Prostaglandin E2 are Associated with Middle Cerebral Artery Occlusion and Hemorrhage in Patients with Moyamoya Disease.

The Progression of Pathophysiology of Moyamoya Disease

Glymphatic System Impairment in the Advanced Stage of Moyamoya Disease

Proteomic Profiling of Exosomes From Hemorrhagic Moyamoya Disease and Dysfunction of Mitochondria in Endothelial Cells.

Dilated perivascular spaces and steno-occlusive changes in children and adults with moyamoya disease

Bioinformatics analysis reveals the landscape of immune cell infiltration and novel immune-related biomarkers in moyamoya disease

Alterations in the Glymphatic System and Association with Brain Structure and Cognitive Function in Moyamoya Disease

Advances in the Pathogenesis of Moyamoya Disease